Society for Immunotherapy of Cancer
@sitcancer.bsky.social
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.
Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: https://sitcancer.org/get-involved/events/calendar #Immunotherapy
November 28, 2025 at 4:30 PM
Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: https://sitcancer.org/get-involved/events/calendar #Immunotherapy
See what is new with SITC by checking out the November edition of the SITC Immune Monitor. Learn about upcoming programs and the most recent society news. Read more here: https://www.sitcancer.org/blogs/sitc-communications/2025/11/25/immune-monitor-november-2025
November 25, 2025 at 6:02 PM
See what is new with SITC by checking out the November edition of the SITC Immune Monitor. Learn about upcoming programs and the most recent society news. Read more here: https://www.sitcancer.org/blogs/sitc-communications/2025/11/25/immune-monitor-november-2025
Registration is open for Next-generation Cellular Therapies, T cell Engagers, and Combinations. Happening March 25–27 in Tucson, AZ or virtual. Join experts in cell therapy, drug development, and IO at Spring Scientific. Register here: https://sitcancer.org/edu/2026-spring-scientific
November 25, 2025 at 2:30 PM
Registration is open for Next-generation Cellular Therapies, T cell Engagers, and Combinations. Happening March 25–27 in Tucson, AZ or virtual. Join experts in cell therapy, drug development, and IO at Spring Scientific. Register here: https://sitcancer.org/edu/2026-spring-scientific
Bispecifics and T cell engagers are transforming care for hematologic malignancies and solid tumors! Join our free webinar Dec. 17 to gain practical strategies for managing toxicities from these modalities and improve patient care. View more: https://ow.ly/gUIq50XwRuI
November 24, 2025 at 3:02 PM
Bispecifics and T cell engagers are transforming care for hematologic malignancies and solid tumors! Join our free webinar Dec. 17 to gain practical strategies for managing toxicities from these modalities and improve patient care. View more: https://ow.ly/gUIq50XwRuI
We are excited to announce the SITC Spring Scientific keynote speaker will be Dr. Kristen M. Hege. Join experts in cell therapy, drug development, and IO at Spring Scientific. Register here: https://sitcancer.org/edu/2026-spring-scientific
November 23, 2025 at 3:40 PM
We are excited to announce the SITC Spring Scientific keynote speaker will be Dr. Kristen M. Hege. Join experts in cell therapy, drug development, and IO at Spring Scientific. Register here: https://sitcancer.org/edu/2026-spring-scientific
Four weeks left before early registration to the #SITC Winter School Program closes. Do not miss the opportunity to attend this program! Held Feb. 16-18, 2026, in Boston, MA, or virtually. Check out the schedule and registration rates: sitcancer.org/edu/winterschool
November 21, 2025 at 2:40 PM
Four weeks left before early registration to the #SITC Winter School Program closes. Do not miss the opportunity to attend this program! Held Feb. 16-18, 2026, in Boston, MA, or virtually. Check out the schedule and registration rates: sitcancer.org/edu/winterschool
Neoadjuvant therapy and more! Understand fundamental IO concepts with our joint Primer with ESMO - European Society for Medical Oncology. Join SITC speakers Dec. 10 at the 2025 ESMO Immuno-Oncology Congress in London, UK: https://ow.ly/NFuI50XuKFN
Daniela Thommen Netherlands Cancer Institute
Daniela Thommen Netherlands Cancer Institute
November 20, 2025 at 5:02 PM
Neoadjuvant therapy and more! Understand fundamental IO concepts with our joint Primer with ESMO - European Society for Medical Oncology. Join SITC speakers Dec. 10 at the 2025 ESMO Immuno-Oncology Congress in London, UK: https://ow.ly/NFuI50XuKFN
Daniela Thommen Netherlands Cancer Institute
Daniela Thommen Netherlands Cancer Institute
Reposted by Society for Immunotherapy of Cancer
What a fantastic opportunity to share our work! Thank you organizers for a great pre-conference event at #SITC25
Looking forward to even more awesome science in the days to come!
Looking forward to even more awesome science in the days to come!
Bernard A. Fox, Michael Geuenich, Catherine Phelps and other international investigators highlight groundbreaking IO advances during the 6th World Immunotherapy Council #SITC25
November 7, 2025 at 4:12 PM
What a fantastic opportunity to share our work! Thank you organizers for a great pre-conference event at #SITC25
Looking forward to even more awesome science in the days to come!
Looking forward to even more awesome science in the days to come!
Reposted by Society for Immunotherapy of Cancer
Congrats @RashaCosman on late breaking oral presentation, showcasing safety and MOA of novel in vivo CAR targeting TROP2 expressing tumors #SITC25 @NECTANSW - led trial from 🇦🇺 👏.
This technology will expand access to solid tumor cell therapy 🌟
This technology will expand access to solid tumor cell therapy 🌟
November 7, 2025 at 7:29 PM
Congrats @RashaCosman on late breaking oral presentation, showcasing safety and MOA of novel in vivo CAR targeting TROP2 expressing tumors #SITC25 @NECTANSW - led trial from 🇦🇺 👏.
This technology will expand access to solid tumor cell therapy 🌟
This technology will expand access to solid tumor cell therapy 🌟
Reposted by Society for Immunotherapy of Cancer
Our #SITC25 recap is out today!
Check out the standout presentations and insights from top institutions and speakers: bit.ly/3LLunuM.
Check out the standout presentations and insights from top institutions and speakers: bit.ly/3LLunuM.
November 19, 2025 at 3:00 PM
Our #SITC25 recap is out today!
Check out the standout presentations and insights from top institutions and speakers: bit.ly/3LLunuM.
Check out the standout presentations and insights from top institutions and speakers: bit.ly/3LLunuM.
The Certificate in Cancer Immunotherapy by SITC is a great way to gain knowledge in the #IO field. By completing eight expert led modules, you can receive CME, CNE, CPE or MOC credit. Consider registering today to enhance your skills. https://www.sitcancer.org/certificate #IOcertificate
November 20, 2025 at 3:30 PM
The Certificate in Cancer Immunotherapy by SITC is a great way to gain knowledge in the #IO field. By completing eight expert led modules, you can receive CME, CNE, CPE or MOC credit. Consider registering today to enhance your skills. https://www.sitcancer.org/certificate #IOcertificate
In the Nov. Issue of the #JITC Digest, Editor-in-Chief Dr. Michael T. Lotze reflects on his experience at #SITC25 and several recent IO meetings. Explore his curated selection of cutting-edge articles, including new insights on LAG-3 blockade and more. View the Nov. Issue: https://ow.ly/fTO150Xun1R
November 19, 2025 at 9:01 PM
In the Nov. Issue of the #JITC Digest, Editor-in-Chief Dr. Michael T. Lotze reflects on his experience at #SITC25 and several recent IO meetings. Explore his curated selection of cutting-edge articles, including new insights on LAG-3 blockade and more. View the Nov. Issue: https://ow.ly/fTO150Xun1R
Tomorrow is the deadline to apply for the SITC Sparkathon class of 2026. Qualified scientists will meet on March 23–25, 2026, in Tucson, AZ. #immunotherapy #cancer #ECR. Apply by Nov. 19: https://www.sitcancer.org/sparkathon #ECR
November 18, 2025 at 4:02 PM
Tomorrow is the deadline to apply for the SITC Sparkathon class of 2026. Qualified scientists will meet on March 23–25, 2026, in Tucson, AZ. #immunotherapy #cancer #ECR. Apply by Nov. 19: https://www.sitcancer.org/sparkathon #ECR
New Journal for ImmunoTherapy of Cancer review: Myeloid metabolism and its role in immunotherapy of cancer jitc.bmj.com/content/13/1...
#JITC #MedSky 🧪
#JITC #MedSky 🧪
November 13, 2025 at 2:40 PM
New Journal for ImmunoTherapy of Cancer review: Myeloid metabolism and its role in immunotherapy of cancer jitc.bmj.com/content/13/1...
#JITC #MedSky 🧪
#JITC #MedSky 🧪
One week left to apply for the SITC Sparkathon class of 2026. Qualified scientists will meet on March 23–25, 2026, in Tucson, AZ. #immunotherapy #cancer #ECR. Apply by Nov. 19: https://www.sitcancer.org/sparkathon #ECR
November 12, 2025 at 6:01 PM
One week left to apply for the SITC Sparkathon class of 2026. Qualified scientists will meet on March 23–25, 2026, in Tucson, AZ. #immunotherapy #cancer #ECR. Apply by Nov. 19: https://www.sitcancer.org/sparkathon #ECR
Join us for tomorrow's #comp #IO webinar: Using Spatial Biology to Monitor Tumor Immune Interactions. Review methods for extracting information on the tumor immune microenvironment from spatial imaging and spatial genomics assays!
Register: https://www.sitcancer.org/edu/webinars/computational
Register: https://www.sitcancer.org/edu/webinars/computational
November 12, 2025 at 4:02 PM
Join us for tomorrow's #comp #IO webinar: Using Spatial Biology to Monitor Tumor Immune Interactions. Review methods for extracting information on the tumor immune microenvironment from spatial imaging and spatial genomics assays!
Register: https://www.sitcancer.org/edu/webinars/computational
Register: https://www.sitcancer.org/edu/webinars/computational
Abstract submissions for Spring Scientific are open through Jan. 15, 2026. Don’t miss this opportunity to share your research with your colleagues and fellow immuno-oncology professionals. Learn more about the program and register: https://sitcancer.org/edu/2026-spring-scientific
November 12, 2025 at 3:02 PM
Abstract submissions for Spring Scientific are open through Jan. 15, 2026. Don’t miss this opportunity to share your research with your colleagues and fellow immuno-oncology professionals. Learn more about the program and register: https://sitcancer.org/edu/2026-spring-scientific
New Journal for ImmunoTherapy of Cancer review: Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directions jitc.bmj.com/content/13/1...
#JITC #ImmunoSky 🧪
#JITC #ImmunoSky 🧪
November 12, 2025 at 2:39 PM
New Journal for ImmunoTherapy of Cancer review: Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directions jitc.bmj.com/content/13/1...
#JITC #ImmunoSky 🧪
#JITC #ImmunoSky 🧪
Reposted by Society for Immunotherapy of Cancer
We had a very productive week at the 40th @sitcancer.bsky.social 2025 meeting. Learned a lot from experts sharing cutting-edge research in immunotherapy, and loved to see my team engaging with attendees from all over the globe. #AntunesLab @uh.edu
November 11, 2025 at 7:59 PM
We had a very productive week at the 40th @sitcancer.bsky.social 2025 meeting. Learned a lot from experts sharing cutting-edge research in immunotherapy, and loved to see my team engaging with attendees from all over the globe. #AntunesLab @uh.edu
Reposted by Society for Immunotherapy of Cancer
MD Anderson Experts Spotlight Key Immunotherapy Advances at 2025 SITC Annual Meeting @mdanderson.bsky.social @sitcancer.bsky.social #SITC25 #oncology
www.onclive.com/view/md-ande...
www.onclive.com/view/md-ande...
MD Anderson Experts Spotlight Key Immunotherapy Advances at 2025 SITC Annual Meeting | OncLive
Researchers at The University of Texas MD Anderson Cancer Center shared insights about how the immune system can be trained to improve patient outcomes.
www.onclive.com
November 11, 2025 at 6:56 PM
MD Anderson Experts Spotlight Key Immunotherapy Advances at 2025 SITC Annual Meeting @mdanderson.bsky.social @sitcancer.bsky.social #SITC25 #oncology
www.onclive.com/view/md-ande...
www.onclive.com/view/md-ande...
Don’t forget to take advantage of SITC’s Career Connection Online Job Board before the deal ends on Nov. 30! Use discount code SITC40YEARS or SITC40YEARSPACK to save 40% on a single, 3- or 5- pack of job posts. Learn more here: careerconnections.sitcancer.org
November 11, 2025 at 4:12 PM
Don’t forget to take advantage of SITC’s Career Connection Online Job Board before the deal ends on Nov. 30! Use discount code SITC40YEARS or SITC40YEARSPACK to save 40% on a single, 3- or 5- pack of job posts. Learn more here: careerconnections.sitcancer.org
Don't miss today's SITC Member-Only Town Hall Webinar, "The State of Play in Immunotherapy Research" from 5–6 p.m. ET! Register: sitc.execinc.com/edibo/THWS25...
November 10, 2025 at 6:25 PM
Don't miss today's SITC Member-Only Town Hall Webinar, "The State of Play in Immunotherapy Research" from 5–6 p.m. ET! Register: sitc.execinc.com/edibo/THWS25...
Reposted by Society for Immunotherapy of Cancer
Great time at the 2025 SITC annual meeting. Learned a lot this week and got to catch up with colleagues! @osuwexmed.bsky.social @osucccjames.bsky.social @sitcancer.bsky.social
November 9, 2025 at 1:36 PM
Great time at the 2025 SITC annual meeting. Learned a lot this week and got to catch up with colleagues! @osuwexmed.bsky.social @osucccjames.bsky.social @sitcancer.bsky.social
Reposted by Society for Immunotherapy of Cancer
Our work was highlighted by @jguerriero.bsky.social at #SITC25 today, session "Cellular Therapies for Solid Tumors, Cell Therapies beyond CAR T Cells." Check out the pre-print on BioRxiv! @sitcancer.bsky.social @sgholamin.bsky.social @nebanovich.bsky.social
November 8, 2025 at 10:26 PM
Our work was highlighted by @jguerriero.bsky.social at #SITC25 today, session "Cellular Therapies for Solid Tumors, Cell Therapies beyond CAR T Cells." Check out the pre-print on BioRxiv! @sitcancer.bsky.social @sgholamin.bsky.social @nebanovich.bsky.social
Congratulations to the 2025 Martin "Mac" Cheever Excellence in Clinical Trial Awardees! These brilliant early career investigators are continuing the trail blazed by Dr. Cheever.
Please join us in recognizing Oluwadunni Emiloju, MD, Emory University and Lee Hong, PhD, Scripps Health.
Please join us in recognizing Oluwadunni Emiloju, MD, Emory University and Lee Hong, PhD, Scripps Health.
November 9, 2025 at 12:00 AM
Congratulations to the 2025 Martin "Mac" Cheever Excellence in Clinical Trial Awardees! These brilliant early career investigators are continuing the trail blazed by Dr. Cheever.
Please join us in recognizing Oluwadunni Emiloju, MD, Emory University and Lee Hong, PhD, Scripps Health.
Please join us in recognizing Oluwadunni Emiloju, MD, Emory University and Lee Hong, PhD, Scripps Health.